Terrence Park

Title: Terrence Park: Innovator in Immune Modulation

Introduction

Terrence Park is a notable inventor based in Hayward, California. He has made significant contributions to the field of immunology through his innovative work on immune cell modulation. His research focuses on enhancing the function of CD8+ T cells, which play a crucial role in the immune response.

Latest Patents

Terrence Park holds a patent for "Fusions with CD8 antigen binding molecules for modulating immune cell function." This patent includes anti-CD8 antigen binding molecules and fusion polypeptides designed to selectively modulate the function of CD8+ T cells over other immune cells. The patent also encompasses polynucleotides encoding these antigen binding molecules and fusion polypeptides, as well as vectors and host cells that incorporate such polynucleotides. Furthermore, it provides methods for producing these antigen binding molecules and fusion polypeptides, along with pharmaceutical compositions that utilize them.

Career Highlights

Terrence Park is currently employed at Asher Biotherapeutics, Inc., where he continues to advance his research in biotherapeutics. His work is pivotal in developing new strategies for immune modulation, which could lead to innovative treatments for various diseases.

Collaborations

Some of his coworkers include Yik Andy Yeung and Ivana Djuretic, who contribute to the collaborative environment at Asher Biotherapeutics, Inc. Their combined expertise enhances the research and development efforts within the company.

Conclusion

Terrence Park is a distinguished inventor whose work in immune modulation has the potential to transform therapeutic approaches in immunology. His patent and ongoing research at Asher Biotherapeutics, Inc. highlight his commitment to advancing medical science.